Tracking sepsis patients in the emergency department
Part of Infections clinical trials.
This study collects information from patients with sepsis (a serious infection that affects the whole body) who come to the emergency department. The goal is to better understand and improve care for people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 15 years old or older.
- You must be seen in the emergency department at Jilin University First Hospital.
- You must have signs of systemic inflammation (your body's response to an infection).
- Within 24 hours of arriving, doctors must find evidence of an infection in your lungs, digestive system, urinary tract, blood, or skin.
- You cannot be pregnant or breastfeeding.
- You must not have active tuberculosis.
- You must agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from adult patients hospitalized with sepsis to better understand how sepsis affects people in China. By joining, you'll help researchers learn more about this condition to improve future care.
This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.
This study tests two new blood tests to see if they can help doctors find sepsis earlier in the emergency department. Sepsis is a serious condition where the body overreacts to an infection, and finding it quickly could lead to faster treatment and better outcomes.
This study looks at how to better recognize and manage sepsis (a serious body-wide reaction to infection) and tailor care to the individual. You may be eligible if you are newly admitted to the emergency department and your care is handled by a rapid response team for sepsis.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
This trial studies how well a simple check (the 'modified shock index') can predict the outlook for patients with sepsis in the emergency department. The goal is to help doctors identify who might be at higher risk so they can provide faster, more targeted care.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.